EORTC CLTF 2018 | Insight into CTCL intratumor heterogeneity may inform disease management
Robert Gniadecki
Robert Gniadecki, MD, PhD, of the University of Alberta, Edmonton, Canada, explores how mutation distribution in cutaneous T-cell lymphoma translates into clinically significant data. This video was recorded at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.
Similar topics
Related videos

Venetoclax monotherapy for relapsed/refractory Waldenström’s macroglobulinemia
Jorge Castillo

Waldenström's PFS unaffected by ibrutinib dose reduction, for now
Jorge Castillo

Anti-CD19 CAR T-cell therapy in combination with ibrutinib for CLL/SLL
Saar Gill

Waldenström’s macroglobulinemia: a link between institution visited and survival
Stephen Ansell

A key take-home message from the EBMT-EHA CAR T-Cell Meeting
Graham Collins
27th September 2018
More from Robert Gniadecki